Can international multiple myeloma patients receive BCMA CAR-T therapy in China?

International patients can seek specialist evaluation for BCMA-targeted CAR-T therapy in China. Eligibility depends on the patient's diagnosis, previous treatments, current disease status, overall condition, and the receiving medical team's assessment.

What medical records are needed to apply for CAR-T treatment in China?

A case review typically requires pathology and bone marrow reports, PET/CT or other imaging, blood and biochemical results, treatment history, previous transplant records, and details of prior therapies. ChinaCureLink can help organize and translate these records for specialist review.

How long does it take to arrange CAR-T treatment in China for an international patient?

The timeline depends on the patient's medical condition, completeness of the records, specialist assessment, treatment eligibility, and CAR-T manufacturing requirements. ChinaCureLink coordinates the medical review and scheduling process so the patient can move from initial assessment to treatment as efficiently as possible.

top of page

ChinaCurelink
a MedeboundHEALTH Company

FREE CONSULTATION

29 Days to Complete Remission: How BCMA CAR-T Treated Relapsed Multiple Myeloma for a Russian Patient in China

ChinaCureLink

Thu Sep 10 2026

6 min read

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

bottom of page